p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: one-year follow-up
about
Targeting cancer gene therapy with magnetic nanoparticlesImpact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples.Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China.Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.Inhibitory Effects of 5-Aza-2'-Deoxycytidine and Trichostatin A in Combination with p53-Expressing Adenovirus on Human Laryngocarcinoma Cells.In vitro effects of Staphylococcus aureus enterotoxin C3 on T cell activation, proliferation and cytokine production.p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study.p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.
P2860
Q26996505-97E355C6-5AA4-4C57-9F18-99BA97E25132Q33891538-6EE1A40A-7E53-47C4-89D2-5501CF58DE91Q33919629-ACFED7FB-0A4E-4A8E-969A-3C951A3B9DB6Q36327007-3BADB7A9-8E7A-4803-ADBA-F247850297D9Q37408971-FD85A947-EBDD-402C-96EF-DC93CD091CFFQ37724094-A5A804C6-0F42-4029-9C9A-EAA993D49A7CQ38286386-1CA34F57-5196-44E8-B69B-1ACF411DC9A3Q39202776-4CC213DC-A659-4366-91A1-FC2A20BD03CBQ40076515-209C66F6-A470-4F04-AB5B-E539569CFD34Q40156290-C9EA26B6-8A87-4043-992A-C0D63710B375Q55669873-ACD2C5E0-D8EC-4806-AD26-48BC41BB759C
P2860
p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: one-year follow-up
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@ast
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@en
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@nl
type
label
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@ast
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@en
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@nl
prefLabel
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@ast
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@en
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@nl
P2093
P2860
P356
P1476
p53 gene therapy in combinatio ...... on for HCC: one-year follow-up
@en
P2093
Yong-Song Guan
P2860
P304
P356
10.3748/WJG.V17.I16.2143
P407
P577
2011-04-01T00:00:00Z